![]()
Cell Banking System Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Cell Banking System market is expected to reach a value of $1.2 billion by 2026, with a CAGR of 8.5%. The increasing demand for cell-based therapies, advancements in biotechnology, and rising prevalence of chronic diseases are driving market growth. Key players include Thermo Fisher Scientific, Merck KGaA, and Hamilton Company.
Request Sample Report
◍ WuXi AppTec
◍ Charles River Laboratories International
◍ Eurofins Scientific
◍ Merck KGaA
◍ Lonza Group Ltd
◍ SGS Ltd
◍ ViruSure GmbH
◍ Austrianova
◍ Goodwin Biotechnology Inc.
◍ Paragon Bioservices
The cell banking system market is highly competitive with key players such as WuXi AppTec, Charles River Laboratories International, Eurofins Scientific, Merck KGaA, Lonza Group Ltd, SGS Ltd, ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices. These companies offer cell banking services to biotech and pharmaceutical companies to store and maintain cells for research and development purposes.
- WuXi AppTec reported sales revenue of $1.16 billion in 2020.
- Charles River Laboratories International reported sales revenue of $2.8 billion in 2020.
- Merck KGaA reported sales revenue of $20.7 billion in 2020.
Request Sample Report
By
Others ◍ Biopharmaceutical Companies ◍ Contract Manufacturing Organizations
Mammalian Cell
Microbial Cell
Insect Cell
Request Sample Report
Request Sample Report
$ X Billion USD